TAKE Solutions Group

TAKE Solutions Group Enabling Business Efficiencies

Contents

•

TAKE Solutions – An Overview

•

Life Sciences

•

Supply Chain Management

•

Financial Overview

•

Going Forward

•

Contents

01

• Creates IP and solutions in “under served domains” (niches)

• Currently operates in the Life Sciences (Pharma/Biotech R&D) and Supply

Chain landscape

• Focuses on improving outcomes for clients by bringing together the best of

Consulting, Analytics, Products and Services

• Is led by a team of Domain Experts and Industry Thought Leaders

02

TAKE

A Global Consulting, Technology Solutions & Services Company Focusing on Specialized Lines of Business

YEARS COUNTRIES OFFICES CUSTOMERS EMPLOYEES REVENUE

12+ 9 13 400+ 1000+ INR 7387 Mn

US HQ,

Princeton

Europe HQ,

London

MEA HQ,

Dubai

Global HQ,

Chennai

1

2

3

4

1 2

3

EUROPE

USA

MIDDLE

EAST &

AFRICA

INDIA

03

Overview

4

Lat Am HQ,

Bogota 5 LAT AM

5

ACCREDITATIONS & RECOGNITIONS

04

Recognitions and Partnership

• ISO 27001 & 9001

• PCMM level 3

• CDISC Solutions Partner

• IDC, a global market intelligence firm, ranked TAKE as

Leader in the life science Drug Safety Services market based

on our demonstrated delivery experience, deep

understanding of drug safety processes & platforms and deep

strategic drug safety expertise

• SDCE 100 Award for Third Consecutive Year

• Employer Branding Award for Excellence in Training

2013

• IDC ranked TAKE as Leader in the life science R&D IT

outsourcing market based on the company‟s capabilities

and future strategies aligned with what customers will

require in three to five years

• A premier global analyst firm recognized and ranked TAKE,

first among large system integrators for industry expertise &

overall customer satisfaction in the Life Sciences Domain

• “Editors‟ Pick” Distinction by Consumer Goods

Technology Magazine

2011

2014

2010

• Ranked 1st at the World HRD Congress

• Ranked 2nd at the Asia‟s Best Employer Brand Awards

05

Alliances and Partnership

LIFE SCIENCES

06

07

FIPCO FIPNET

Changing Trends in LS Outsourcing

Pharma Company

Pharma Company

08

Market Landscape

Market looking for niche, specialized solution providers

Recent Trends

in LS

and

Pharma

Business

Market Forecast

on Technology

Spending

$15.9

Billion

$2.3

Billion

$4

Billion $1

Billion

09

Business Practices Overview

U.S &

Europe

U.S, Europe,

APAC, MENA

U.S & APAC

U.S & ROW

Implementation

6 4

4

4

2

6

3

Clinical

Regulatory

Safety

Technology

Products/

IP

Service

Lines Geography

10

Business Practices Overview

Clinical Regulatory Safety

Clinical

Development

Bio Statistical

Programming Regulatory

Submissions Safety

eCTD DMF

TRMF SPL/PLR

PPM eTMF

SAS – Bio Statistics

Framework

CDISC Accelerators

11

Service Lines

TAKE has a strong suite of technology products supporting its various offerings across business segments

Clinical

Practice

Implementation of

strategies for the

clinical data lifecycle

• Data Management

• Data Standardization

• Biostatistics & SAS

Programming

• Clinical Information

Systems

Regulatory

Practice

Full range of

compliance initiatives

with electronic

document processing

• Electronic

Submission

• Electronic Trial

Master File

Management

• Pharmaceutical

Validation

• Regulatory

Compliance

Systems

Safety

Practice

Scalable safety

solutions

• Pharmacovigilance

Strategy

• Pharmacovigilance

Systems Strategy

• Safety &

Pharmacovigilance

Systems

• Safety Business

Services

Technology

Specialized

services

• Content

Management

• Analytics

12

Marquee Clients

Pharmaceuticals

Bio-Tech

CROs, Academia

Devices

Generics

13

Differentiators

TAKE’s differentiated approach to markets • Large and mid-market segment : Functional Service Provider

• Small and medium segment : Full Service Provider

Unique combination of deep domain expertise and technical skills • Significant IP creation : Nets, PharmaReady, Accelerators

• Development of accelerators over largely adopted solutions in the industry, e.g.

(i) Platform based iCommittee for DMC

(ii) CDISC Accelerators for e-Submission activities

New “go to market” strategy – www.navitas.net

Strategic & deep partnerships with industry players

14

Leadership in IT Outsourcing & Drug Safety Services

• Data Management

• Data Standardization

• Biostatistics & SAS

Programming

• Clinical Information

Systems

The players in the LS IT

Outsourcing and Drug Safety

Services markets fall under two

categories:

• Category 1: Consulting companies

such as Accenture, TAKE and iGate.

• Category 2: IT giants such as TCS,

Infosys, Cognizant and HCL.

TAKE is a leader among leaders

in both the LS R&D IT Outsourcing

and Drug Safety Services

Vendor Assessments

IDC has ranked the companies in this industry based on the following two criteria:

• Capabilities: based on current capabilities of the players and how well-aligned

they are to customer needs.

• Strategies: based on how well the players‟ future strategies aligns with

customers‟ expected requirements in three to five years.

SUPPLY CHAIN

MANAGEMENT

15

16

Business Practices Overview

North America,

APAC & MENA

North America,

APAC & MENA

North America

4 3

6

3 1

2

Mobility

Collaboration

Engineering

Services

Products/

IP

Service

Lines Geography

Engineering

Services

Collaboration

Mobility

Intellectual Properties

17

18

Service Lines

Enterprise

Mobility and

WMS

• Oracle Data Collection

and Warehouse

Automation

• Mobile Sales & Route

Delivery

• Barcode & RFID

Management and

Compliance

Supply Chain

Collaboration

• Demand Collaboration &

Purchasing Collaboration

• Contract Manufacturing

Collaboration

• Supplier On-boarding/

Enablement

• Vendor Managed

Inventory

• Returns Management

• Request for Quote

Collaboration

• Quality Collaboration

• E-Invoice & AP

Automation

• Ship Confirmation

Collaboration

• Supplier Collaboration

Analytics

Engineering

Services

• Value Engineering

• Drawing,

Documentation,

Design & Prototyping

• Reverse Engineering

19

Diverse Global Customer Base

Oil & Gas

High Tech

Industrial

Consumer

Products

Pharma &

Medical

FMCG /

Food

FINANCIAL OVERVIEW

20

21

FY 2014 FY 2013 FY 2012 FY 2011 FY 2010

6-yr CAGR : 16.6%

10

8

6

4

2

0

FY 2015

REVENUE

Earnings Per Share (in INR) EBITDA

3,518

5,003

7,036

8,320 8,155

2.70

5.83

7.13 6.61

4.83

FY 2014 FY 2013 FY 2012 FY 2011 FY 2010

2,500

5,000

7,500

0

10,000

INR

million

6-yr CAGR : 15.7%

FY 2015

7305

6-yr CAGR : 23.5%

2000

1,500

1,000

500

0

FY 2014 FY 2013 FY 2012 FY 2011 FY 2010

INR

million

FY 2015

520

1,451 1,614

1,473

1,033

1,495 5.82

22

Financials Income Statement Summary

Quarter Ended Year Ended

(Figures in INR mn, except EPS) 30-Jun-15 31-Mar-15 31-Mar-14 Net Sales/Income from Operations 2,286 7,304 8,155

Other Income 185 82 62

Total Income 2,471 7,386 8,217

Profit Before Interest, Amortization, Depreciation & Tax 481 1,495 1,473

Profit before Interest & Tax 287 899 704

Profit before Tax* 445 854 628

Net Profit 395 699 580

Diluted Earnings Per Share (INR) (Annualized) 13.16 5.82 4.83

Balance Sheet Summary As on

30-Jun-15 31-Mar-15 31-Mar-14

Book Value per share (INR) 46.9 43.7 39.2

Net Worth (INR Mn) 6,000 5,805 5,183

Debt (INR Mn) 1,937 2,085 2,015

Cash & Cash Equivalents (INR Mn) 1,137 1,257 1,274

DSO (days) 102 117 99

Net D/E (x) 0.1 0.2 0.2

23

Our People Strength - Thought Leaders

Dr. Bruce Fadem Dr. Graham Higson Dr. Steve Arlington

• Former CIO of Wyeth

• Spent 12 years with Bank of

America Corporation in a

variety of senior information

technology positions

• Served as the Chairman of

Temple University Fox School of

Business IT Advisory Board and

Editor in Chief for their Institute

for Business and Information

Technology (IBIT) Report

• Has spent 35+ years in the

pharmaceutical industry

• Member of the NDA Regulatory

Advisory Board and served as

Managing Director of NDA

Advisory Services

• Held leadership roles at GE

Healthcare, Pfizer and

AstraZeneca

• Has been a member of EFPIA

And PhARMA regulatory affairs

committees, the CMR

Regulations Advisory Board, and

the TOPRA Regulatory Advisory

Council

• Pharma industry veteran of 35+

years. Former Global Life

Sciences Head of PWC

• Has led and built major

pharmaceutical consultancies

for PA Technology, Coopers and

Lybrand, IBM, and latterly PWC

• Led the future series called

Pharma 2005, Pharma 2010, and

Pharma 2020

24

Our People Strength - Thought Leaders

Dr. Demi Lappas Prof. G Raghuram

• Served as a CIO at companies

like Warner-Lambert, Pharmacia

and Enzon Pharmaceuticals

• Served in senior IT positions in

companies such as Borden,

Nabisco Foods and Colgate-

Palmolive Co.

• Past member of the

Pharmaceutical Industry systems

Association (PISA), past

president of the NJ Chapter of

SIM

• Served on the Board of

Governors for the Uniform Code

Council for two terms

• Distinguished expert in Supply

Chain and Logistics

Management, Infrastructure &

Services management and

related subjects

• Served as consultant to over 53

organizations in India and

overseas

• Currently the „Indian Railways

Chair Professor‟ at the Indian

Institute of Management,

Ahmadabad

• Member of boards and

government committees related

to Infrastructure and Logistics

25

Our People Strength – Key Management

Ram Yeleswarapu Jim Tizzard Marty Boom

• Co-founder of the life sciences

business of TAKE

• Has worked with Pharma

companies since 1995, Merck,

Pfizer, Amgen, etc

• Acknowledged thought leader in

the Clinical data management

space

• Management and consulting

roles in Automotive,

Aerospace & Defence, Hi-Tech,

and Healthcare followed, along

with the opportunity to work

across a range of geographies in

Europe, USA and Asia

• Has initiated, led, and

supported Life Sciences

businesses in transforming

performance in development,

regulatory, & Manufacturing for

over 16 years

• Led global business

improvement assignments for

clients like Bayer HealthCare,

Pfizer, Johnson & Johnson,

Roche etc. in most areas

of Pharmaceutical Drug

Development and Supply Chain

• One of the initiators and early

leaders of pvnet®; Navitas‟

network for Heads of

Pharmacovigilance

26

Our People Strength – Key Management

G. Ramesh Brad Huff Reji Nair

• Has over 26 years of rich

professional experience in

Supply Chain Management in

areas like Supply Chain

Designing, Procurement,

Inventory Planning and

Management, Warehousing,

Distribution and Transportation

• Has been associated with MNCs

like Pepsi, HCL, Philips,

Sembcorp Logistics and

Inchcape group of companies

• Member of the Institute of

Logistics and Transport and

visiting faculty at the Loyola

Institute of Business

Administration (LIBA)

• Has over 20 years of experience

in enterprise supply chain

solutions

• Served in progressive

management and sales roles

with leading enterprise solution

providers such as IBM, Sterling

Commerce, PeopleSoft and JD

Edwards

• Worked with clients at JDE and

PeopleSoft to implement an

initial ERP system in order to

improve execution inside the

four walls

• Has over 20 years of experience

in the IT industry and has

worked in the Mobile Computing

industry since 1995

• Has worked in the TATA Group in

India, Al Rostamani Group in

UAE and large business groups in

Saudi Arabia

27

Acquisitions

2011

2007

2006

2008

WCI Consulting

UK

28

Plans in Progress

• NAVITAS to be market representation of

core business

• 'TAKE Innovation' to incubate IP

creation and new LS lines

› Currently underway on “signal detection”

› Pilot phase in LS “big data”

LS

• Focus only on profitable segments of

mobility, collaboration and engineering

services

• Launch of Conflict Minerals services

SCM

TAKE Solutions Group

THANK YOU